The goal of biomedical innovation is to maximize scientific discoveries to improve individual health, which has enabled the discovery of life-savings vaccines, and effective treatments for conditions such as heart disease, diabetes, cancer, and common bacterial infections. While there has been substantial progress in the development of innovative treatments over the past several decades, millions of Americans still lack the treatments and drugs they need due to the surmounting costs, time and resources, and regulatory restrictions that are required to develop new drugs, medical products, and therapies.
A researcher, seen through a window, observes a DNA colony development at Bioaster Technology Research Institute in Lyon, October 31, 2014. Bioaster conducts research in microbiology related to infectious diseases. REUTERS/Robert Pratta (FRANCE - Tags: SCIENCE TECHNOLOGY BUSINESS HEALTH)
Gene editing: New challenges, old lessons
March 15, 2016, Walter D. Valdivia
Walter Valdivia discusses the ethics and patent controversies surrounding a new gene editing technique called CRISPR-Cas9. Several conferences of scientists have failed to reach a consensus on the bioethics of CRISPR, and biotechnology companies continue to receive funding based on contested CRISPR patents.
October 27, 2015
October 19, 2015
October 14, 2015
July 30, 2015, William Hoffman
July 28, 2015
July 24, 2015
June 23, 2015
May 18, 2015, Gregory W. Daniel and Mark B. McClellan
May 19, 2015
May 18, 2015
View All Research on Biomedical Innovation ›Show 10 More
You have not selected any newsletters.
The Brookings Institution is a nonprofit organization devoted to independent research and policy solutions. Its mission is to conduct high-quality, independent research and, based on that research, to provide innovative, practical recommendations for policymakers and the public. The conclusions and recommendations of any Brookings publication are solely those of its author(s), and do not reflect the views of the Institution, its management, or its other scholars.
1775 Massachusetts Ave, NW,
Washington, DC 20036
© 2016 The Brookings Institution